These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17565473)

  • 21. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
    Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
    Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical protocol for the management of malignant hyperthermia.
    Kollmann-Camaiora A; Alsina E; Domínguez A; Del Blanco B; Yepes MJ; Guerrero JL; García A
    Rev Esp Anestesiol Reanim; 2017 Jan; 64(1):32-40. PubMed ID: 27633384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant hyperthermia and its differential diagnosis].
    Hüttemann K; Nowe T; Köhrmann M; Anetseder M; Schellinger PD
    Fortschr Neurol Psychiatr; 2009 Apr; 77(4):203-11. PubMed ID: 19347791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing the number of diagnostic mutations in malignant hyperthermia.
    Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
    Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fulminant malignant hyperthermia episode in a patient with ryanodine receptor gene mutation p.Tyr522Ser.
    Girard T; Suhner M; Levano S; Singer M; Zollinger A; Hofer CK
    Anesth Analg; 2008 Dec; 107(6):1953-5. PubMed ID: 19020143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia.
    Aleman M; Riehl J; Aldridge BM; Lecouteur RA; Stott JL; Pessah IN
    Muscle Nerve; 2004 Sep; 30(3):356-65. PubMed ID: 15318347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overlapping Mechanisms of Exertional Heat Stroke and Malignant Hyperthermia: Evidence vs. Conjecture.
    Laitano O; Murray KO; Leon LR
    Sports Med; 2020 Sep; 50(9):1581-1592. PubMed ID: 32632746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.
    Anderson AA; Brown RL; Polster B; Pollock N; Stowell KM
    Anesthesiology; 2008 Feb; 108(2):208-15. PubMed ID: 18212565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel ryanodine receptor mutation that may cause malignant hyperthermia.
    Kaufmann A; Kraft B; Michalek-Sauberer A; Weigl LG
    Anesthesiology; 2008 Sep; 109(3):457-64. PubMed ID: 18719443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hyperthermia.
    Dunn D
    AORN J; 1997 Apr; 65(4):728, 731, passim; quiz 755-8, 760-2. PubMed ID: 9093738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene.
    Cherednichenko G; Ward CW; Feng W; Cabrales E; Michaelson L; Samso M; López JR; Allen PD; Pessah IN
    Mol Pharmacol; 2008 Apr; 73(4):1203-12. PubMed ID: 18171728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
    Kaufmann A; Kraft B; Michalek-Sauberer A; Weindlmayr M; Kress HG; Steinboeck F; Weigl LG
    Anesth Analg; 2012 May; 114(5):1017-25. PubMed ID: 22415532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant hyperthermia: new developments in diagnosis and clinical management].
    Dépret T; Krivosic-Horber R
    Ann Fr Anesth Reanim; 2001 Dec; 20(10):838-52. PubMed ID: 11803844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
    Johannsen S; Klingler W; Schneiderbanger D; Heiderich S; Roewer N; Schuster F
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Several interacting genes influence the malignant hyperthermia phenotype.
    Robinson R; Hopkins P; Carsana A; Gilly H; Halsall J; Heytens L; Islander G; Jurkat-Rott K; Müller C; Shaw MA
    Hum Genet; 2003 Feb; 112(2):217-8. PubMed ID: 12522565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild clinical and histopathological features in patients who carry the frequent and causative malignant hyperthermia RyR1 mutation p.Thr2206Met.
    Rueffert H; Wehner M; Ogunlade V; Meinecke C; Schober R
    Clin Neuropathol; 2009; 28(6):409-16. PubMed ID: 19919814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
    Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures].
    Grander W
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):407-16. PubMed ID: 27272514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.